Nasdaq

AIM ImmunoTech Inc. Highlights Study Linking COVID-19 to Increased Risk of ME/CFS and Ampligen's Potential as a Therapeutic Solution

A study links COVID-19 infection to higher ME/CFS rates, supporting Ampligen's potential as a treatment for affected individuals. AIM ImmunoTech Inc. has commented on a recently published study in the ...
News Medical

Long COVID and ME/CFS patients could benefit from a coordinated treatment strategy

People suffering from Long COVID or Myalgic Encephalomyelitis /Chronic Fatigue Syndrome (ME/CFS) could benefit from a coordinated treatment strategy, a new University of Otago study has found. The ...
Science Daily

Chronic fatigue syndrome: Number of patients is expected to double due to long-term effects of the COVID-19 pandemic

The number of ME/CFS patients is expected to rise drastically due to long-term effects of the COVID-19 pandemic. Scientists have now identified possible biomarkers that could improve the diagnosis and ...
Morningstar

Annals of Family Medicine: Mayo Clinic study details treatment options family medicine physicians may consider to treat ME/CFS and long COVID

PROVIDENCE, R.I., April 30, 2026 /PRNewswire/ -- A new Mayo Clinic study published in Annals of Family Medicine identifies a range of medication and supplement options that family medicine physicians ...
Medscape

'Deep Phenotyping' Identifies Abnormalities in ME/CFS

Postinfectious myalgic encephalomyelitis/chronic fatigue syndrome (PI-ME/CFS) is a distinct, centrally mediated condition, with evidence of autonomic, immune, and metabolic dysfunction, new "deep ...
STAT

Delay of British chronic fatigue syndrome guidelines is a setback for people with long Covid

The National Institute for Health and Care Excellence (NICE), a British agency charged with developing clinical guidelines for medical conditions, was expected to release new recommendations on August ...